Related Experiment Video
Updated: May 8, 2026

Visualizing the DNA Damage Response in Purkinje Cells Using Cerebellar Organotypic Cultures
Published on: December 27, 2024
Histone deacetylase regulation of ATM-mediated DNA damage signaling
K Ted Thurn1, Scott Thomas, Paromita Raha
1Corresponding Author: Pamela N. Munster, Division of Hematology and Oncology, Department of Medicine, University of California, 1600 Divisadero, Room A719, Box 1711, San Francisco, CA 94143. pmunster@medicine.ucsf.edu.
Abstract:
Ataxia-telangiectasia mutated (ATM) is a major regulator of the DNA damage response. ATM promotes the activation of BRCA1, CHK2, and p53 leading to the induction of response genes such as CDKN1A (p21), GADD45A, and RRM2B that promote cell-cycle arrest and DNA repair. The upregulation of these response genes may contribute to resistance of cancer cells to genotoxic therapies. Here, we show that histone deacetylases (HDAC) play a major role in mitigating the response of the ATM pathway to DNA damage. HDAC inhibition decreased ATM activation and expression, and attenuated the activation of p53 in vitro and in vivo. Select depletion of HDAC1 and HDAC2 was sufficient to modulate ATM activation, reduce GADD45A and RRM2B induction, and increase sensitivity to DNA strand breaks. The regulation of ATM by HDAC enzymes therefore suggests a vital role for HDAC1 and HDAC2 in the DNA damage response, and the potential use of the ATM pathway as a pharmacodynamic marker for combination therapies involving HDAC inhibitors.
Insights
Histone deacetylases (HDAC) regulate the DNA damage response by mitigating the Ataxia-telangiectasia mutated (ATM) pathway. Inhibiting HDACs decreases ATM activation, enhancing cancer cell sensitivity to genotoxic therapies.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- The Ataxia-telangiectasia mutated (ATM) pathway is crucial for DNA damage response, activating genes that promote cell-cycle arrest and repair.
- Upregulation of ATM-responsive genes can lead to cancer cell resistance against genotoxic treatments.
Purpose of the Study:
- To investigate the role of histone deacetylases (HDAC) in regulating the ATM pathway's response to DNA damage.
- To explore the therapeutic potential of targeting HDACs in combination with genotoxic therapies.
Main Methods:
- In vitro and in vivo experiments were conducted to assess the effects of HDAC inhibition on ATM pathway activation.
- Specific depletion of HDAC1 and HDAC2 was performed to evaluate their individual contributions.
Main Results:
- HDAC inhibition was found to decrease ATM activation and expression, as well as attenuate p53 activation.
- Depletion of HDAC1 and HDAC2 modulated ATM activation, reduced induction of GADD45A and RRM2B, and increased sensitivity to DNA strand breaks.
Conclusions:
- HDAC enzymes, particularly HDAC1 and HDAC2, play a significant role in the DNA damage response by regulating the ATM pathway.
- The ATM pathway can serve as a pharmacodynamic marker for combination therapies involving HDAC inhibitors and genotoxic agents.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

